In addition to the killing of tumor cells by CD8+ cytotoxic T cells, there is strong evidence that Th1 responses, and more specifically the balance between Th1 and Th17 responses, are important for patient outcome in colon cancer [19]. This evidence concerns the gene CD8A and malignant colon neoplasm.